These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6725790)

  • 21. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigens of Ambrosia elatior (short ragweed) pollen. III. Crossed radioimmunoelectrophoresis of ragweed-allergic patients' sera with special attention to quantification of IgE responses.
    Løwenstein H; Marsh DG
    J Immunol; 1983 Feb; 130(2):727-31. PubMed ID: 6217252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy with monomethoxypolyethylene glycol modified allergens.
    Dreborg S; Akerblom EB
    Crit Rev Ther Drug Carrier Syst; 1990; 6(4):315-65. PubMed ID: 2186872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies on tree pollen allergens. XI. Trials on the regulation of IgE response in mice using modified birch pollen allergens.
    Vik H; Elsayed S
    Int Arch Allergy Appl Immunol; 1986; 81(4):315-21. PubMed ID: 3781639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: a double-blind study.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    J Allergy Clin Immunol; 1997 Jul; 100(1):30-8. PubMed ID: 9257784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of ragweed hay fever with urea-denatured antigen E.
    Norman PS; Ishizaka K; Lichtenstein LM; Adkinson NF
    J Allergy Clin Immunol; 1980 Oct; 66(4):336-41. PubMed ID: 6158532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with short ragweed fraction A:D-glutamic acid:D-lysine polymer in ragweed hay fever.
    Butterfield JH; Gleich GJ; Yunginger JW; Zimmermann EM; Reed CE
    J Allergy Clin Immunol; 1981 Apr; 67(4):272-8. PubMed ID: 6970763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isotypic and antigenic restriction of the blocking antibody response to ryegrass pollen: correlation of rye group I antigen-specific IgG1 with clinical response.
    Moss RB; Hsu YP; Kwasnicki JM; Sullivan MM; Reid MJ
    J Allergy Clin Immunol; 1987 Feb; 79(2):387-98. PubMed ID: 3819220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. II. Response after ragweed immunotherapy.
    Marsh DG; Meyers DA; Freidhoff LR; Ehrlich-Kautzky E; Roebber M; Norman PS; Hsu SH; Bias WB
    J Exp Med; 1982 May; 155(5):1452-63. PubMed ID: 6951004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy.
    Lichtenstein LM; Ishizaka K; Norman PS; Sobotka AK; Hill BM
    J Clin Invest; 1973 Feb; 52(2):472-82. PubMed ID: 4119162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
    Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF
    J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
    Hayek B; Vangelista L; Pastore A; Sperr WR; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R
    J Immunol; 1998 Dec; 161(12):7031-9. PubMed ID: 9862740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parental hay fever reinforces IgE to pollen as pre-clinical biomarker of hay fever in childhood.
    Hatzler L; Panetta V; Illi S; Hofmaier S; Rohrbach A; Hakimeh D; Bauer CP; Hoffman U; Forster J; Zepp F; Schuster A; Stock P; Wahn U; Keil T; Lau S; Matricardi PM
    Pediatr Allergy Immunol; 2014 Jun; 25(4):366-73. PubMed ID: 24953296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.